187%+ gains and counting: A new list of AI-picked stocks for September IS NOW LIVE

August saw broad gains (+2.62% S&P 500, +3.93% Nasdaq, +1.34% Dow for the month) alongside Q2 earnings-driven stock breakouts and a rotation from crowded mega-cap trades into deep-value names. The article highlights an InvestingPro AI-model track record, citing +187.39% since launch (vs. the S&P 500’s outperformance of +105.94%). Example picks listed include Salesforce (+39.95% in Aug), Peabody Energy (+39.72%), and Haemonetics (+89.88% since first flagged), supported by catalysts such as margin strength, valuation discount metrics, and a Citi “Buy” upgrade with a $90 target for Haemonetics.

Analysis

This reads more like a factor-flow signal than a fundamental breakpoint. The common thread is capital rotating toward names with operating leverage, visible cash generation, and lower starting multiples; that tends to favor cyclicals and turnarounds over duration-sensitive growth when real yields and energy are firm. The best second-order beneficiaries are the ETFs/indices behind the move: equal-weight/value baskets and small-cap cyclicals can keep outpacing cap-weighted growth if this breadth regime persists.

Among the named stocks, the asymmetric setups are in BTU, METC, DK, NUE, and MATV, where incremental buying can move the tape faster than fundamentals because these names trade on revision momentum and factor sponsorship, not just earnings. The main loser is not a single ticker but crowded growth exposure; if investors keep funding these value trades by trimming software/quality, multiple compression can show up first in the most expensive duration names even without any earnings miss.

The biggest contrarian point is that this is also a marketing-heavy list, so near-term performance can be front-loaded and then fade once the rebalance is absorbed. HAE looks fundamentally better than most of the basket, but after a strong run the next 1-3 months are about whether estimates keep moving up, not whether the story is real. Falsifiers for the broader rotation are simple: a dovish Fed repricing, a sharp oil retrace, or a risk-off move that pulls breadth back into mega-cap defensives.

Key Decisions for Investors

• Long BTU/METC basket vs short AMRC for the next 4-8 weeks; this expresses high beta cyclicals with cleaner operating leverage against a levered balance-sheet story. Cut if coal pricing rolls over or AMRC regains earnings momentum.
• If seeking a cleaner macro pair, long XLE or XME vs short XLK/QQQ for 1-3 months. The trade works only if rates stay sticky and breadth remains value-led; exit on a dovish Fed repricing or oil downtrend.
• Treat HAE as a hold, not a chase: buy on a 5-8% pullback or sell upside call spreads into strength over the next 1-2 months. Falsify on another guidance raise or a new large contract that extends revenue visibility.
• Avoid adding to CRM/IT purely on this note; if you want exposure, wait for the next earnings print and use a call spread instead of stock. The risk is paying full price for a rotation already partially discounted.